Osagie O. Imasogie has been appointed Chair of the University of Pennsylvania Carey Law School’s Board of Overseers, effective January 1, 2021. Current Chair Perry Golkin, for whom the Law School’s Golkin Hall is named, is rotating out of the position and will remain an active member of the Board of Overseers.
Imasogie has been a member of the Law School’s Board since 2006, where he will now transition to the role of Chair. Imasogie received his Law degrees from the University of Ife, Ile-Ife and the Nigerian Law School, and continued his education earning LLM degrees at both the London School of Economics and Political Science in 1984 and Penn’s Law School in 1985. A dedicated and engaged teacher, alumni supporter, and civic leader, he has over 35 years of experience in law, finance and business management, healthcare, and the pharmaceutical industry.
“I am thrilled to continue working closely with Osagie Imasogie in his leading role as the Chair of the Board to the University of Pennsylvania Carey Law School,” said Ted Ruger, Dean of the Law School. “Osagie has been an engaged and supportive Board member and Adjunct Professor for many years, and I have come to deeply value his advice on a range of topics. As a graduate of the LLM program and with his impressive experience, he will be an exceptional leader of the Board, and my colleagues and I look forward to his guidance on strategy and priorities.”
Imasogie is a serial entrepreneur and investor. He is the senior managing partner and co-founder at PIPV Capital, a fully integrated Private Equity and Venture Capital Fund which specializes in Life Sciences, principally in the pharmaceutical sector.
In the spirit of propelling entrepreneurship and in support of cross-disciplinary scholars whose work bridges the interconnected fields of law and technology at Penn Carey Law, Osagie and his wife Losenge Imasogie, created the Imasogie Professorship in Law & Technology. To enhance the physical space for the cross-disciplinary study of law, Osagie and his wife Losenge established the Imasogie Gateway which serves as the main entrance into Golkin Hall.
Osagie has held senior commercial and R&D positions within pharmaceutical companies such as GSK, SmithKline, DuPont Merck and Endo, where he was the founding General Counsel and SVP for Corporate Development. Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a practicing attorney with the Law Firm, Schnader, Harrison, Segal & Lewis.
Imasogie continues to be an Adjunct Professor at the University of Pennsylvania Carey Law School, where he teaches a seminar on “Intellectual Property and National Economic Value Creation” and has served as the I. Grant Irey Adjunct Professor.
“I am looking forward to working with Dean Ruger and my colleagues on the Board to continue the trajectory of growth and innovation that we have seen at the Law School,” said Imasogie. “As we emerge from the COVID-19 pandemic and strive for a more just and equitable society, the next few years will be critical as legal education continues to evolve to meet changing needs and demands.”
Imasogie is also a member of the Board of Trustees of the University. He serves as Chairman and Founder of Zelira Therapeutics, Ilera Holdings and Ilera Holistic. Osagie was the Founder and Chairman of Ilera Healthcare, Ception Therapeutics Inc. and Trigenesis Therapeutics Inc. In addition, he serves on the Board of a number of financial institutions such as FS-KKR Capital Corp. (NYSE: FSK), Haverford Trust and StoneRidge Investment. He is active in philanthropic, educational and artistic pursuits and serves on the Executive Committee of the Board of the Philadelphia Orchestra and the Philadelphia Museum of Art.
Perry Golkin, who is stepping down from the position, has served as Chair since 2013. He continues to serve as a Trustee of the University of Pennsylvania, an Overseer at the Law School, a Trustee of Penn Medicine, and on the Board of Advisors of the Institute for Law & Economics. Golkin is currently an Adjunct Professor at the Law School and Co-Founder and Chief Executive Officer at Public Pension Capital.
“Perry’s leadership has been instrumental to the Law School’s success over the past decade and more,” said Ruger. “I look forward to continuing our partnership and working with him as an active member of the Board. During his tenure as Chair, Perry has been instrumental in the advancing the University of Pennsylvania Carey Law School into a new era of legal education. He remains steadfast in his dedication the Law School and his guidance has been immeasurable.”
“I have valued the opportunity to work closely with Osagie as the Chair of the Board of Overseers and look forward to continuing to do so under his leadership,” noted Golkin. “The Law School is in a unique position to train future leaders who can solve complex problems, nationally and globally.”